Insider buying...up day again tomorrow ! They like what they see,so do I !!
Inovio Pharmaceuticals logoInovio Pharmaceuticals Inc (NASDAQ:INO) Director Morton Collins acquired 10,000 shares of Inovio Pharmaceuticals stock in a transaction on Tuesday, June 28th. The stock was purchased at an average cost of $9.13 per share, for a total transaction of $91,300.00. Following the purchase, the director now owns 142,291 shares in the company, valued at $1,299,116.83. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.
Shares of Inovio Pharmaceuticals Inc (NASDAQ:INO) traded up 2.39% during trading on Wednesday, hitting $9.43. The stock had a trading volume of 2,246,089 shares. The firm’s 50-day moving average is $10.42 and its 200 day moving average is $8.16. Inovio Pharmaceuticals Inc has a 52-week low of $4.50 and a 52-week high of $11.69. The firm’s market cap is $689.30 million.
Inovio Pharmaceuticals (NASDAQ:INO) last issued its earnings results on Monday, May 9th. The biopharmaceutical company reported ($0.11) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.14) by $0.03. The business had revenue of $8.10 million for the quarter, compared to the consensus estimate of $4.75 million. During the same quarter in the previous year, the business posted ($0.17) earnings per share. On average, analysts expect that Inovio Pharmaceuticals Inc will post ($0.75) EPS for the current year.
Center are testing a genetically engineered Zika virus vaccine they say has exceeded expectations in animal trials, requiring only one shot to stave off the disease linked to devastating birth defects.
“The protection was striking,” said lead researcher Daniel Barouch, director of the Center for Virology and Vaccine Research at Beth Israel. “This gives us an option for a safe and effective vaccine for humans.”
The vaccine prevented infection in all 45 mice that were exposed to high levels of the virus, according to a paper published yesterday in the scientific journal Nature. Some mice were exposed four weeks after vaccination, and others were exposed after eight weeks.
The method was tested on strains of the mosquito-borne illness from both Brazil and Puerto Rico.
The results are “welcome news and a step forward” in the fight against Zika, Barouch said, which is thought to cause microcephaly — characterized by stunted brain development and abnormally small skulls — in babies whose mothers contracted the illness while pregnant.
The researchers developed a so-called DNA vaccine — an approach that uses a piece of the virus’ DNA rather than injecting an entire version of the deactivated virus. The portion of DNA is stitched into a circular structure that has been engineered in the lab and serves as a carrier. Though no DNA vaccines have been federally approved, they have been called “the vaccine of the future” by portions of the research community, Barouch said.
The California-based Inovio announced this month it has approval to start a Phase 1 trial of its own DNA vaccine, co-developed by Korea’s GeneOne Life Science and made at its Texas-based subsidiary VGXI.
F***stein... Krammer in drag...
Sentiment: Strong Buy
Clyde... it could not have been said better..where is Bernie even today??
"We plan to dose our first subjects in the next weeks,40 healthy subjects and expect to report phase I interim results later this year," 2 weeks not 2 years..
Sentiment: Strong Buy
June 20 (Reuters) - Drug developer Inovio Pharmaceuticals Inc and its partner GeneOne Life Sciences Inc said they had received approval to start an early stage human trial testing their Zika vaccine.
The early-stage study will enroll 40 healthy subjects and evaluate safety, tolerability and immune response generated by the vaccine GLS-5700.
"We plan to dose our first subjects in the next weeks and expect to report phase I interim results later this year," Inovio CEO J Joseph Kim said.
(Reporting by Amrutha Penumudi in Bengaluru; Editing by Shounak Dasgupta)
I call it criminal and a breach of obligation.Showing more of how the whole thing is loosing what we once called integrity..Shame.
Its a lock..